Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Interstate BancSystem
FIBK
|
+$15.9M |
| 2 |
PR
Permian Resources
PR
|
+$11.1M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$10.4M |
| 4 |
Haemonetics
HAE
|
+$4.46M |
| 5 |
CHCT
Community Healthcare Trust
CHCT
|
+$3.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
|
+$32.3M |
| 2 |
ALE
Allete
ALE
|
+$24.5M |
| 3 |
Enviri
NVRI
|
+$20.7M |
| 4 |
Wabtec
WAB
|
+$18M |
| 5 |
Texas Capital Bancshares
TCBI
|
+$14.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.89% |
| 2 | Technology | 20.8% |
| 3 | Financials | 15.23% |
| 4 | Healthcare | 14.79% |
| 5 | Consumer Discretionary | 8.99% |
Similar funds
Aristotle Capital Boston's Q3 2024 Portfolio in Review
As of Q3 2024, Aristotle Capital Boston held 129 positions worth $3.02B, up 1.6% from $2.97B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aristotle Capital Boston withdrew a net $175M in Q3 2024, closing 2 positions and reducing 88 holdings. Its most notable exit was Enviri, an estimated $20.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
Against the trend, Aristotle Capital Boston opened a new position in First Interstate BancSystem worth $16.3M.
- Aristotle Capital Boston's largest Q3 2024 buy was First Interstate BancSystem: 532,655 shares worth $16.3M.
- Aristotle Capital Boston added most to Chart Industries in Q3 2024, an estimated $10.4M increase.
- Aristotle Capital Boston's biggest Q3 2024 reduction was PetIQ, Inc. Class A Common Stock, cutting an estimated $32.3M.
- Aristotle Capital Boston fully exited Enviri in Q3 2024, selling an estimated $20.7M.
- Aristotle Capital Boston's ten largest holdings make up 22% of its $3.02B portfolio in Q3 2024.
- Aristotle Capital Boston opened 3 new positions and closed 2 in Q3 2024.
- Aristotle Capital Boston's portfolio value rose 1.6% quarter-over-quarter to $3.02B.
Based on Aristotle Capital Boston's 13F filing for Q3 2024, filed 14 Nov 2024.